Frontiers

Signal Transduction and Targeted Therapy | Bispecific Antibody Study Targeting the IL-17/IL-36 Pathogenic Hub for Hidradenitis Suppurativa

Signal Transduction and Targeted Therapy | Camrelizumab Plus Chemotherapy as Induction Therapy Followed by Concurrent Chemoradiotherapy and Consolidation in Limited-Stage Small Cell Lung Cancer: A Randomized Phase II Trial

Signal Transduction and Targeted Therapy | Bispecific Antibody Study Targeting the IL-17/IL-36 Pathway Hub for the Treatment of Hidradenitis Suppurativa

Signal Transduction and Targeted Therapy | A Randomized Phase II Study of Camrelizumab-Induced Sequential Therapy Combined with Chemoradiotherapy and Consolidation for Limited-Stage Small Cell Lung Cancer

Cancer Research | HDAC Inhibitors Reshape Immune Circuits to Enhance Dual Checkpoint Blockade Efficacy in Metastatic Breast Cancer

Nature Microbiology | Mechanistic Analysis of Protection Provided by CD8+ T Cells via Zika Virus E Protein Fusion Loop Mutant Vaccine

Antibodies | Molecular Architecture, Signaling Mechanisms, and Clinical Biomarkers of Immune Checkpoint Receptors and Ligands: A Comprehensive Review

Signal Transduction and Targeted Therapy | COVID-19 Triggers Pulmonary Tumor Outgrowth through Hypoxia- and Inflammation-Induced VEGF-Dependent Angiogenesis

Exploration | A PD-L1 Nanobody-Engineered Synthetic RNA Virus Enhances Hepatocellular Carcinoma Immunotherapy by Interfering with PCSK9 and Upregulating MHC-I

Cancer Communications | Targeting TREM2+ and TIMD4+ Macrophages Reprograms the Tumor Microenvironment and Enhances PD-1 Blockade Efficacy in Cholangiocarcinoma